These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 11655169)
81. The regulation of human experimentation in the United States--a personal odyssey. Katz J IRB; 1987; 9(1):1-6. PubMed ID: 11649890 [No Abstract] [Full Text] [Related]
82. IRBs and research with human biological materials. Maloney DM Hum Res Rep; 1999 Jan; 14(1):2. PubMed ID: 11657556 [No Abstract] [Full Text] [Related]
83. The concept of the IRB and bureaucratic reality: an exchange of letters. van Eys J; Levine RJ IRB; 1984; 6(4):8-10. PubMed ID: 11649563 [No Abstract] [Full Text] [Related]
84. "Evaluation of human subject protections in schizophrenia research conducted by the University of ..." (Part III). Maloney DM Hum Res Rep; 2000 Jan; 15(1):5-6. PubMed ID: 11658036 [No Abstract] [Full Text] [Related]
85. Human experimentation: issues before the hospital administrator. Wielk CA Hosp Health Serv Adm; 1977; 22(3):4-25. PubMed ID: 12085914 [No Abstract] [Full Text] [Related]
86. Balancing moral principles in federal regulations on human research. Ackerman TF IRB; 1992; 14(1):1-6. PubMed ID: 11652041 [No Abstract] [Full Text] [Related]
87. The informed-consent policy of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use: knowledge is the best medicine. Miller MD Cornell Int Law J; 1997; 30(1):203-44. PubMed ID: 11660583 [No Abstract] [Full Text] [Related]
88. Research and ethics committees. Nightingale SL Lancet; 1983 Jun; 1(8338):1389. PubMed ID: 11644258 [No Abstract] [Full Text] [Related]
89. Obtaining "informed consent": controversy over radiation tests focuses attention on rules for human subjects. Wheeler DL Chron High Educ; 1994 Jan; 40():8-9, 16. PubMed ID: 11658067 [No Abstract] [Full Text] [Related]
91. Is this a job for the IRB? The case of the ELISA assay. Holder AR IRB; 1985; 7(6):7-8. PubMed ID: 11649689 [No Abstract] [Full Text] [Related]
92. The burgeoning law of medical experimentation involving human subjects. Bryant LE John Marshall J Pract Proced; 1974; 8(1):19-51. PubMed ID: 11663465 [No Abstract] [Full Text] [Related]
93. The Baby Fae case. Hubbard LL Med Law; 1987; 6(5):385-96. PubMed ID: 3309521 [No Abstract] [Full Text] [Related]
94. Genetic research as therapy: implications of "gene therapy" for informed consent. Churchill LR; Collins ML; King NM; Pemberton SG; Wailoo KA J Law Med Ethics; 1998; 26(1):38-47, 3. PubMed ID: 11067584 [TBL] [Abstract][Full Text] [Related]
95. Waivers proposed for emergency studies. Wolfgang L Science; 1995 Oct; 270(5233):25-6. PubMed ID: 7569946 [No Abstract] [Full Text] [Related]
96. From the Food and Drug Administration. Nightingale SL JAMA; 1995 Nov 22-29; 274(20):1578. PubMed ID: 7474231 [No Abstract] [Full Text] [Related]
97. To be or not to be: waiving informed consent in emergency research. McCarthy CR Kennedy Inst Ethics J; 1995 Jun; 5(2):155-62. PubMed ID: 10184356 [No Abstract] [Full Text] [Related]
98. Acting without asking: an ethical analysis of the Food and Drug Administration waiver of informed consent for emergency research. Adams JG; Wegener J Ann Emerg Med; 1999 Feb; 33(2):218-23. PubMed ID: 9922420 [TBL] [Abstract][Full Text] [Related]
99. Institutional review boards; request for information. U.S. Food and Drug Administration Fed Regist; 1981 Sep; 46(176):45538-9. PubMed ID: 11655488 [No Abstract] [Full Text] [Related]